NDC 72288-505-01 - CHILDRENS IBUPROFEN
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 72288-505
- Requested NDC
- 72288-505-01
- Package NDCs from labels
- 72288-505-01, 72288-505-34
- Manufacturer
- Amazon.com Services LLC
- Effective date
- 2026-10-22
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| CHILDRENS IBUPROFEN - Amazon.com Services LLC | Amazon.com Services LLC | 2026-10-22 | HUMAN OTC DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Optase | GLYCERIN | Scope Health Inc | 10c3e31d-779d-8ff6-e063-6294a90acd39 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 86c14327-ffc7-806e-e053-2991aa0aaf92 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Ibuprofen | IBUPROFEN | REMEDYREPACK INC. | 404df13d-4ada-4324-9eed-e21f5d5043a4 | 2026-10-23 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Clear Eyes Maximum Redness Relief | NAPHAZOLINE HYDROCHLORIDE AND GLYCERIN | Prestige Brands Holdings, Inc. | c3b0e344-68dd-4c35-bf46-744e612a5b15 | 2026-10-23 | Warnings | PDC6A3C0OX |
| Ibuprofen and famotidine | IBUPROFEN AND FAMOTIDINE | Ascend Laboratories, LLC | 4493d4cd-ca8e-4b0a-9b65-b75e55bf8b9e | 2026-10-23 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | PD-Rx Pharmaceuticals, Inc. | 0fa4cd66-66ad-4ec9-b38c-6b5840df39df | 2026-10-22 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| CHILDRENS IBUPROFEN | IBUPROFEN | Amazon.com Services LLC | b857c13a-b1e2-4f6a-bb66-4bac431cfa33 | 2026-10-22 | Warnings | ANDA074937 72288-505-34 72288-505-01 72288-505 72288050501 197803 d5a00e07-6e37-43a8-8800-94a27b08926a b857c13a-b1e2-4f6a-bb66-4bac431cfa33 WK2XYI10QM |
| Fendall 1000 Pure Flow | PURIFIED WATER | Protective Industrial Products, Inc. | 55a2f4da-bb1e-8ead-e063-6394a90af72e | 2026-10-21 | Warnings | 059QF0KO0R |
| Ibuprofen | IBUPROFEN | Redpharm Drug | 5e426629-8733-366a-e063-6394a90a8e39 | 2026-10-20 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | AAA Pharmaceutical, Inc. | 4aba1bf2-8146-04fa-e063-6294a90a8a21 | 2026-10-20 | Warnings | WK2XYI10QM |
| childrens ibuprofen | IBUPROFEN | Amazon.com Services LLC | 760151df-1f53-458c-9f9f-321c62de96d3 | 2026-10-19 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | PD-Rx Pharmaceuticals, Inc. | 606f839a-d4b3-4437-8ea1-58f41c484d6f | 2026-10-19 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Walgreens Sterile Soothing Eye Wash | PURIFIED WATER | Walgreens | a62e3294-abd6-48dc-81b1-62a809bdc968 | 2026-10-19 | Warnings | 059QF0KO0R |
| childrens ibuprofen | IBUPROFEN | Amazon.com Services LLC | 755a346b-3c5e-41ca-8bf7-3d084dabee24 | 2026-10-19 | Warnings | ANDA074937 197803 WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Northwind Health Company, LLC | 2f12a20c-4293-d18a-e063-6294a90a3afc | 2026-10-16 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Rohto Max Strength | NAPHAZOLINE HYDROCHLORIDE, POLYSORBATE 80 | The Mentholatum Company | e4b49550-1ca3-4bd7-854d-409b53fa5e26 | 2026-10-16 | Warnings | 6OZP39ZG8H |
| ibuprofen | IBUPROFEN | PD-Rx Pharmaceuticals, Inc. | 96bff700-bca3-4b94-b8a2-379102721db8 | 2026-10-16 | Warnings | WK2XYI10QM |
| 365 whole foods market ibuprofen | IBUPROFEN | Whole Foods Market, INC. | e914472b-c785-4c73-b37c-4d459166cf41 | 2026-10-15 | Warnings | WK2XYI10QM |
| Clear Eyes Cooling Redness Relief | GLYCERIN AND NAPHAZOLINE HYDROCHLORIDE | Prestige Brands Holdings, Inc. | 38d14e99-e4c8-431b-b106-578eeb38bf3c | 2026-10-15 | Warnings | PDC6A3C0OX |
| Artificial Tears | GLYCERIN | Preferred Pharmaceuticals Inc. | dd646c72-8f47-43c6-a734-db0dcc8cd4d1 | 2026-10-14 | Warnings | PDC6A3C0OX 3NXW29V3WO |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.